From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

“I don’t want people to presume that this Trump presidency will be bad for PR,” Edelman told PRWeek. “I think there will be ...

Cytokinetics is hoping to launch a drug targeting a chronic heart condition next year but while it waits on regulatory ...

California this year took the final step in opening Medi-Cal, its Medicaid program, to every eligible resident regardless of ...

A new federal watchdog audit is ratcheting up pressure on government officials to crack down on billions of dollars in overcharges linked to Medicare Advantage home visits.

Havas is to offer key staff up to €37.5 million (£31.5 million/$40.3 million) in share awards as part of its Dutch stock market listing, following its planned separation from parent company Vivendi in ...

OpenAI’s much-anticipated SearchGPT, that was initially launched as a prototype in July, has become live to paid subscribers within the platform. The AI-backed search engine offers real-time data, ...

The campaign is titled Artful Ingenuity, which shares its initials with artificial intelligence, and underscores Eversana ...

Nearly three years ago, these jurisdictions signed an agreement promising annual reports “specifying the activities and ...

If President-elect Donald Trump and a Republican Senate try to roll back reproductive health rights or pursue a widely ...

The mental health app airs ads of pure silence between news outlets’ election coverage — and everyone’s a fan.

CDMO Avid Bioservices will be taken private by GHO Capital Partners and Ampersand Capital Partners in a deal worth $1.1 ...